ArticleJournal of arrhythmia2025
Cardiac arrhythmias in cancer patients using the nationwide claim-based database in Japan.
Article in Journal of arrhythmia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Toward ED Based Cardio Oncology Pathways From a Nationwide Arrhythmia Cohort.Journal of arrhythmia · 2025Article
- Cardiac arrhythmias in cancer patients using the nationwide claim-based database in Japan.Journal of arrhythmia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardio-oncology has recently developed as a new discipline. No study using a Nationwide Claim-Based Database has examined the association between cancer and arrhythmia in Japan. Methods: JROAD-DPC (Japanese Registry Of All cardiac and vascular Diseases - Diagnosis Procedure Combination) is a nationwide claims database using data from the Japanese Diagnosis Procedure Combination/Per Diem Payment System. Among 11 297 525 records found between April 2012 and March 2021 from 1119 hospitals, 2 976 362 patients with arrhythmias were studied and divided into categories using cancer. Results: The prevalence rate of cancers was 7.51% of the patients hospitalized for arrhythmias, and the prevalence of cancer increased with time. The prevalence rate of Atrial fibrillation (AF) and/or atrial flutter (AFL) was 70.6% and 60.7% of arrhythmic patients with and without cancer, respectively. Pneumonia (7.41%) was the first major infectious complication in arrhythmic patients with cancers. Arrhythmic patients with cancers had significantly higher Barthel index (65.2 at admission and 72.5 at discharge) and prevalences of hyperuricemia (HU) and chronic kidney disease (CKD) (6.13% and 9.67%) than those without cancer. The rate of emergency hospitalization was higher in arrhythmic patients with cancers than those without cancer (58.9% vs. 57.6%). Conclusion: Cancers were frequently observed in arrhythmic patients, and the prevalences increased with time. AF and/or AFL were the most common arrhythmias of cancer patients. Arrhythmic patients with cancers had significantly higher Barthel index and prevalences of HU and CKD than those without cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.